Can Severe Disability Trigger a Founder Buy-Sell Agreement?

Introduction

A founder’s severe disability can disrupt ownership, management, financing, and succession in a closely held Philippine company. A properly drafted shareholder buy-sell agreement may address this risk by requiring the affected founder’s shares to be purchased upon the occurrence of an objectively defined disability.

The agreement should not rely on vague descriptions such as “serious illness,” “mental incapacity,” or “inability to work.” It should identify the medical event that activates the sale, the persons authorized to make the determination, the valuation method, the payment terms, and the company’s authority to complete the transaction.

Under Philippine law, the agreement operates primarily as a contractual arrangement among the shareholders and, when properly structured, the corporation. It must remain consistent with the Revised Corporation Code of the Philippines, the corporation’s articles of incorporation and by-laws, restrictions on the transfer of shares, and applicable rules on the corporation’s acquisition of its own shares.

What Is a Shareholder Buy-Sell Agreement?

A shareholder buy-sell agreement is a contract that regulates the transfer of shares upon specified events. Common triggering events include death, permanent disability, retirement, insolvency, divorce, loss of required qualifications, or a proposed sale to an outsider.

In a founder-owned corporation, the agreement usually provides for one of three arrangements:

• Cross-purchase: the remaining shareholders purchase the disabled founder’s shares;
• Corporate redemption: the corporation purchases its own shares; or
• Hybrid purchase: the corporation or the remaining shareholders may purchase the shares according to a specified order or option.

The agreement should also state whether the sale is mandatory or optional. If the purpose is contingency planning, the document should clearly provide that the qualifying disability automatically creates an obligation to sell and a corresponding obligation to purchase, subject to the agreement’s valuation and closing procedures.

Governing Philippine Corporate Rules

The Revised Corporation Code of the Philippines, R.A. No. 11232 recognizes shares as proprietary interests in a corporation and permits the articles of incorporation to provide for different classes of shares, rights, privileges, and restrictions, subject to law.

Restrictions on the transfer of shares should be reflected in the corporation’s articles of incorporation, by-laws, and certificates of stock when the restriction is intended to bind purchasers in good faith. A restriction should not effectively impose conditions that are more burdensome than an option allowing existing shareholders or the corporation to purchase the shares on reasonable terms.

The Supreme Court has held that a power of attorney must be interpreted according to its terms and purpose, rather than through an interpretation that defeats the parties’ evident intent. In Olaguer v. Purugganan, Jr., et al., G.R. No. 158907, 17 August 2007, the Court considered the ordinary meaning of “absence” and “incapacity” in determining the scope of an authority to sell shares. The case also recognized that irregularities in the transfer process do not necessarily invalidate a consummated sale where the principal consented to the transaction and received the consideration.

These principles support careful drafting. The agreement should define disability expressly instead of leaving the parties to litigate whether a particular medical condition falls within an undefined term.

Corporate Purchase of the Disabled Founder’s Shares

If the corporation itself will purchase the shares, the transaction must comply with the corporate rules governing the acquisition of treasury or redeemable shares and any other applicable provisions of the Revised Corporation Code.

A buy-sell agreement cannot, by itself, remove statutory requirements applicable to a corporate repurchase. The corporation should therefore confirm its authority, available funds, accounting treatment, and compliance with the applicable requirements before closing the transaction.

Where the purchase involves substantially all corporate assets, a different approval rule applies. Under Section 39 of R.A. No. 11232, a sale or disposition of all or substantially all corporate assets requires approval by stockholders representing at least two-thirds of the outstanding capital stock, in addition to board authorization. This rule concerns the disposition of corporate assets, not an ordinary purchase of a shareholder’s shares, but the distinction should be maintained in transaction documents.

The corporation should also avoid treating the buyout as an informal transfer of corporate property without proper board approval, accounting entries, and documentation. A board resolution, updated stock and transfer records, and a properly executed share purchase agreement are ordinarily necessary.

Defining the Medical Trigger

The medical trigger is the provision that determines when the buyout obligation arises. It should contain objective standards, procedural safeguards, and a clear date of effectiveness.

A well-drafted provision may define a qualifying disability as a physical or mental condition that:

• prevents the founder from performing the material functions of the founder’s position or professional role;
• continues for a stated minimum period, such as 180 or 365 consecutive days;
• is expected to continue for a specified additional period or is medically determined to be permanent; and
• is certified by one or more independent physicians with appropriate qualifications.

The parties should distinguish between temporary disability and permanent or prolonged disability. Temporary illness may activate leave, interim management, or a suspension of voting participation, while permanent or prolonged disability may activate the mandatory purchase.

The agreement should also address conditions such as cognitive impairment, loss of legal capacity, coma, degenerative disease, and inability to communicate. A founder may be physically present but unable to understand or approve business decisions. Conversely, a founder may have a physical limitation but remain capable of exercising shareholder rights.

Who Determines Whether Disability Exists?

The agreement should identify the decision-maker and the evidence required. Possible mechanisms include certification by one independent physician, certification by two physicians, or a determination by a panel consisting of physicians selected by the parties.

For greater reliability, the agreement may provide that:

• the company selects one physician and the founder selects another;
• the two physicians appoint a third physician if their findings differ;
• the determination must be based on specified medical records and examinations;
• the physicians must disclose any financial or personal conflict of interest; and
• the medical determination is final for purposes of triggering the purchase, subject only to fraud, manifest error, or procedural irregularity.

Medical information should be handled confidentially and consistently with the Data Privacy Act of 2012 and the parties’ consent arrangements. The agreement should limit disclosure to information reasonably necessary to determine whether the contractual trigger has occurred.

Notice and Waiting Period

The agreement should state who may give notice of the alleged disability, how notice must be served, and when the waiting period begins. Notice may be given by the founder, a family member, the board, another shareholder, or an authorized representative.

A typical clause requires written notice accompanied by available medical documentation. The founder may be given a reasonable period to undergo an independent examination before the disability is formally confirmed.

The parties should define whether the purchase obligation arises:

• on the date the disability first occurs;
• on the date the minimum disability period ends;
• on the date the medical panel issues its determination; or
• on the date written notice is received.

This date affects valuation, voting rights, dividends, insurance proceeds, and the allocation of corporate risks. It should not be left to implication.

Valuation Mechanics

The valuation clause is often the most disputed part of a buy-sell agreement. The parties should choose a method that is understandable, commercially defensible, and capable of producing a result without prolonged negotiation.

Common valuation methods include:

Method	How It Works	Common Concern
Agreed value	The parties periodically sign a schedule stating the value per share.	The value may become outdated if not regularly updated.
Book value	The price is based on the company’s net assets shown in its financial statements.	It may not reflect goodwill, intellectual property, or earning capacity.
Fair market value	An independent valuation considers the company’s financial and commercial position.	The parties may disagree on discounts and assumptions.
Formula value	The price is calculated using earnings, revenue, cash flow, or another agreed formula.	The formula may produce unreasonable results after a major business change.
Appraisal process	One or more independent appraisers determine the value under stated instructions.	It may be more expensive and slower than a fixed formula.

The agreement should specify the valuation date, the financial statements to be used, the treatment of debt, cash, contingent liabilities, shareholder loans, intellectual property, goodwill, and pending litigation.

It should also state whether minority, lack-of-control, or lack-of-marketability discounts apply. In a mandatory buyout among existing shareholders, the parties should expressly address these discounts because their application can materially reduce the purchase price.

Payment Terms and Security

A mandatory buyout may impose a substantial financial burden on the purchasing shareholders or the corporation. The agreement should therefore specify whether payment will be made in cash, installments, a promissory note, or a combination of these methods.

Important payment provisions include:

• the down payment and installment schedule;
• interest and late-payment charges;
• the maturity date;
• security for unpaid installments;
• the effect of death of the selling founder before full payment; and
• the remedies for default.

If installment payments are permitted, the selling founder or the founder’s estate may require security such as a pledge of shares, a mortgage, a corporate guarantee, or another legally enforceable arrangement. The agreement should also clarify when voting rights, dividends, and economic ownership transfer.

Life and Disability Insurance

Insurance may provide funds for a buyout, but the policy structure must match the selected purchase mechanism. In a cross-purchase arrangement, the shareholders may own policies on one another. In a corporate redemption arrangement, the corporation may own the policy and receive the proceeds.

The agreement should identify the policy owner, insured person, beneficiary, required coverage amount, premium obligations, policy review schedule, and treatment of insufficient proceeds. Insurance proceeds should not automatically be treated as the full value of the shares unless the parties expressly intend that result.

Management During Incapacity

A shareholder’s disability does not automatically transfer ownership of the shares or automatically authorize another person to exercise all shareholder rights. Ownership, management authority, and authority to act for the founder are separate matters.

For an ordinary corporation, the parties may use a properly executed power of attorney, succession provisions, board arrangements, and a buy-sell agreement. The authority granted should identify the transactions covered and the conditions under which it may be exercised.

For a One Person Corporation, Section 124 of R.A. No. 11232 requires the single stockholder to designate a nominee and an alternate nominee. The nominee may take the place of the single stockholder as director and manage the corporation’s affairs upon the stockholder’s death or incapacity, subject to the authority and limitations stated in the articles of incorporation.

SEC Memorandum Circular No. 07, Series of 2019 further provides that, in case of incapacity, the nominee may take over management as director and president, and the single stockholder may resume management upon recovery. This management mechanism does not, by itself, constitute a transfer or buyout of the shares.

Founder’s Shares and Special Voting Rights

Founders’ shares may carry rights and privileges different from those of other shares, subject to the Revised Corporation Code and applicable restrictions. Section 7 of R.A. No. 11232 limits an exclusive right to vote and be voted for in the election of directors to a period not exceeding five years from incorporation.

The agreement should therefore distinguish between special voting rights and the economic ownership of the founder’s shares. A disability-triggered buyout should state whether the founder retains voting rights during the certification and waiting period, and whether those rights cease upon the valuation date, closing date, or another defined event.

Any arrangement involving foreign ownership, nationality restrictions, or a business reserved for Philippine citizens must also be reviewed under applicable nationality rules. A transfer that would reduce Filipino ownership below a legally required percentage may be prohibited or incapable of registration.

Contract Interpretation and Enforceability

The agreement should be read together with the articles of incorporation, by-laws, share certificates, subscription agreements, and any shareholders’ agreement. Conflicting documents create uncertainty and may prevent the corporation from recording the transfer.

In Universal Food Corporation v. Court of Appeals, G.R. No. 29155, 13 May 1970, the Supreme Court emphasized that the parties’ intention, as shown by the language of the contract and their conduct, governs contractual interpretation. A buy-sell agreement should therefore use consistent terms and avoid provisions that suggest the transaction is merely optional when the parties intended a mandatory purchase.

The agreement should expressly address breach, specific performance, damages, attorney’s fees, dispute resolution, and the governing law. It should also state whether the corporation is a party, because obligations imposed only on shareholders may not automatically bind the corporation unless it has properly consented and the arrangement is consistent with corporate authority.

Typical Disability Scenario

Assume that a founder owns 60% of a closely held Philippine corporation and the remaining shareholders own the balance. The shareholders’ agreement provides that a permanent disability exists when two independent physicians certify that the founder cannot perform the material functions of the founder’s position and the condition has continued for 180 days.

After the certification, the remaining shareholders are required to purchase the founder’s shares at fair market value determined by an independent valuation expert. The agreement provides for a 20% down payment, the balance payable over three years with interest, and security through a pledge of the purchased shares.

This arrangement is more certain than a clause stating that the founder’s shares may be purchased upon “serious illness.” It identifies the medical evidence, waiting period, valuation procedure, payment terms, and consequences of nonpayment.

Drafting Checklist

Before signing a disability-triggered buy-sell agreement, the parties should confirm the following:

• Trigger: Is disability defined by functional inability, diagnosis, duration, permanence, or a combination?
• Medical process: Who selects the physicians, and how are conflicting opinions resolved?
• Notice: When and how must the event be reported?
• Buyer: Will the purchaser be the corporation, the remaining shareholders, or both?
• Corporate authority: Are the required board, shareholder, and regulatory approvals available?
• Valuation: What is the valuation date, method, and treatment of discounts?
• Funding: Are insurance, retained earnings, loans, or installment payments available?
• Payment security: What protects the seller if the purchaser defaults?
• Interim management: Who manages the company while the disability is being determined?
• Document consistency: Do the articles, by-laws, certificates, and shareholder agreement contain compatible provisions?

Final Observations

A founder’s severe disability can trigger a buyout only when the governing agreement clearly makes disability a purchase event and the transaction complies with Philippine corporate law. The most important protections are an objective medical standard, an independent determination process, a precise valuation formula or appraisal procedure, and realistic funding and payment provisions.

The company should review the agreement periodically, particularly after changes in ownership, business value, management structure, insurance coverage, or nationality composition. The agreement should also be coordinated with the founder’s estate plan, powers of attorney, corporate records, and succession arrangements.

About Nicolas and De Vega Law Offices

 Nicolas and de Vega Law Offices is a full-service law firm in the Philippines.  You may visit us at the 16th Flr., Suite 1607 AIC Burgundy Empire Tower, ADB Ave., Ortigas Center, 1605 Pasig City, Metro Manila, Philippines.  You may also call us at +632 84706126, +632 84706130, +632 84016392 or e-mail us at [email protected]. Visit our website https://ndvlaw.com.